We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Assistant Cell Image Analyzer for Hematology Labs Released

By LabMedica International staff writers
Posted on 19 Jul 2012
AACC 2012: A cell image analyzer for hematology laboratories automates and simplifies the cell differential process by locating and preclassifying white blood cells.

Called EasyCell and manufactured by Medica Corporation (Bedford, MA, USA), the analyzer employs optical pattern recognition software to automatically locate white cells on a blood smear. More...
It digitally stores their images, preclassifies, and then presents them for review—grouped by cell type—on a liquid crystal display (LCD) display.

The analyzer also presents images of red cells and platelets, enabling red cell morphology and platelet estimates. With its 30-position carousel, the EasyCell offers walkaway operation and a stat slide port permits immediate testing without disrupting a sample run.

EasyCell reduces sample review times by 50% over the manual differentiation process using microscopes, while helping the technologist achieve improved efficiency, accuracy, and precision.

Doug Moe, vice president of business development, Medica Corporation, said, “The EasyCell assistant lowers cost by substantially cutting the time technologists require to perform manual blood cell differentials and correctly classify normal cells."

A clinical evaluation at the Children’s Hospital Boston (Boston, MA, USA) confirmed the EasyCell efficacy in the hematology laboratory environment.

In an announcement at the 2012 Annual Meeting of the American Association for Clinical Chemistry (AACC) Expo being held July 15-19, 2012 in Los Angeles (CA, USA), the company said it is now accepting orders for the EasyCell solution and will have instruments available for global shipment during the third quarter of 2012.

Related Links:

Medica Corporation
Children’s Hospital Boston




New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Pathology

view channel
Image: The new methyl-copying PCR method preserves DNA methylation patterns during amplification (Photo courtesy of Syndex Bio)

Novel mcPCR Technology to Transform Testing of Clinical Samples

DNA methylation is an important biological marker used in the diagnosis and monitoring of many diseases, including cancer. These chemical modifications to DNA influence gene activity and can reveal early... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.